Jonathan Monson, EVP and CFO of Boston Scientific (BSX), acquired 9,908 shares of common stock. This acquisition was made on August 10, 2026, through a discretionary 401(k) rebalancing.
Boston Scientific CFO Adds Shares Via 401(k) Rebalancing
executive-transactions401kstock-acquisitioncorporate-governance



